Remcom Announces Enhanced Biological Thermal Sensor and Other...

State College, PA (PRWEB) August 27, 2014

Remcom announces an update to XFdtd® 3D Electromagnetic Simulation Software[1] with new features for the biomedical industry. The central biomedical addition in the release is an enhanced Biological Thermal Sensor, exclusive to the Bio-Pro version of the software. XFdtd Bio-Pro is a specialty version of XFdtd, developed to calculate the biological effects of electromagnetic fields. In addition, MATLAB® export functionality has been added to all versions to expand engineers’ post-processing options.

The Biological Thermal Sensor allows metals and other non-biological objects to be included in temperature rise computations. The calculations consider the effects of conductive heat transfer between thermally connected materials, blood perfusion, metabolic processes, and general RF heating.

The new sensor provides crucial data to engineers studying temperature effects of RF exposure. Analyses include therapeutic heating devices; MRI heating in patients, including effects of implants, probes, and electrodes; microwave thermal ablation; and implantable devices.

Rodney Korte, product manager for XFdtd, said, “Remcom’s customers in the magnetic resonance community have relied on XFdtd for SAR modeling and MRI safety analysis for many years; however, there was a need for an improved thermal solver that could account for non-biological objects such as metal probes. Remcom has carefully researched our customers’ processes and most pressing problems in order to offer a complete solution. The new release reflects our ongoing commitment to this market’s needs and our product development philosophy of continually adding features that customers directly request.”

In addition to the thermal sensor, the new release includes MATLAB export functionality. All data available through XFdtd’s Result Browser can be exported to MATLAB and CSV formats. This enables full post-processing of data with MATLAB’s extensive mathematical and visualization capabilities. Exportable result types include rotating B+/- and SAR results, grid vertex locations and mesh material properties needed for custom SAR post-processing, and more.

There are many additional usability enhancements in the release including PrOGrid Project Optimized Gridding™, a new capability that simplifies the process of optimizing both accuracy and runtime when creating grids. Information on all of the new enhancements can be found at http://www.remcom.com/xf7-latest-enhancements[2].

About XFdtd and the Bio-Pro Version: XFdtd Bio-Pro[3] provides users with a bundled collection of important biomedical EM calculation capabilities such as Specific Absorption Rate (SAR) analysis, VariPose® Mesh Repositioning, and Hearing Aid Compatibility (HAC). Bio-EM analyses include imaging devices and MRI coil design and tuning, SAR and field analysis, implantable devices (pacemakers, diagnostic equipment), field exposure from radiating sources (cell phones and other antennas), human models and phantoms, and regulation/certification.

Both the Pro and Bio-Pro versions of XFdtd include XStream® GPU Acceleration[4], geometric modeler and postprocessor, shared memory multiprocessor (MPM) capability, XACT Accurate Cell Technology®, and a comprehensive variety of 3D CAD and PCB import modules. XFdtd users without an active Remcom Professional Support contract can upgrade to the latest version of Release 7 by contacting sales(at)remcom(dot)com.

About Remcom: Remcom provides innovative electromagnetic simulation software[5] and leads the market in FDTD-based modeling and simulation. Remcom’s products are used for antenna design, bio-EM effects, MRI, microwave circuits, RFID, military and defense applications, EMC/EMI, and more. Remcom is committed to its customers’ unique needs, offering flexible licensing options for installations of all sizes as well as custom engineered solutions.


Share on TwitterShare on Google+Email a friendRemcom Announces Enhanced Biological Thermal Sensor and Other...Share on TwitterShare on Google+

Source http://www.prweb.com/releases/remcom/xfdtd-bio/prweb12118717.htm